Skip to content

Author

Zi-Yi Yang

We have 1 of 49 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Mitochondrial guardian and therapeutic target: The promise of TFAM in acute kidney injury.

Evidence showing that TFAM upregulation, whether through pharmacological interventions or genetic manipulation, consistently protects against tubular cell injury, preserves mitochondrial function, and attenuates inflammation across diverse AKI models is integrated.

Luyao Zhang, Zi-Yi Yang, Rushuang Yue et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.